Data Characteristics
Peptide drug clinical trial pre-screening data originates from clinical research databases, patent literature, academic papers, and internal experimental reports from drug development organizations. This data typically exists in a mixed format of structured and unstructured information. Structured data includes trial protocols, patient inclusion criteria, biomarker data, pharmacokinetic (PK) and pharmacodynamic (PD) parameters, and adverse event reports, often presented as CSV, JSON, or database records. Unstructured data encompasses detailed clinical observation records, pathology reports, medical imaging descriptions, and researcher notes, primarily stored in PDF, DOCX, or plain text formats. Data update frequencies vary; clinical trial registration information might update weekly, while detailed trial reports could release quarterly or annually at milestone points or after trial completion. Core fields specific to this data type include peptide sequences, modification information, and target sites, potentially containing complex chemical structural formulas or IUPAC naming conventions.
Constraints on Deployment and Upgrade
The heterogeneous nature of peptide drug data sources requires deployment solutions to effectively integrate different data formats. For example, PDF and DOCX files need text extraction and structured processing. The periodic nature of data updates means the system must support scheduled incremental updates and version management to ensure pre-screening results are based on the latest information. The complexity of peptide sequences and chemical structure fields demands higher requirements for text embedding models and knowledge graph construction. Deployment must consider the model's ability to understand these special characters and semantics. Furthermore, the sensitive nature of clinical trial data dictates that deployment environments must meet stringent data security and privacy compliance requirements, such as access control and data encryption. During upgrades, introducing new models or algorithms requires compatibility with existing data structures and historical data to avoid high data migration costs or inconsistent results.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
UPLOAD_FILE_MAX_SIZE | 500 MB | Clinical trial reports often contain numerous charts and detailed descriptions, leading to large individual file sizes. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Processing large PDF or DOCX files, especially those with complex tables and peptide sequence information, requires longer parsing times. |
maxContext | 32000 | Peptide drug clinical trial protocols and research reports are typically lengthy, requiring a larger context window to capture complete trial designs and results. |
Chunk size | 800–1200 characters | Ensures each text chunk contains sufficient peptide structure, pharmacokinetic, or adverse event descriptions, while avoiding excessively long segments that dilute key information. |
Recall count | Top 10–15 entries | The pre-screening phase requires comprehensive consideration of multiple relevant trials or literature snippets to reduce the risk of omissions. |
Similarity threshold | 0.78–0.85 | Clinical trial pre-screening demands high matching accuracy. A threshold that is too low may introduce irrelevant information, while one that is too high may miss potentially relevant information. |
Common Pitfalls
- Model list not updated: After modifying
config.json, the FastGPT service or related containers were not restarted, preventing the configuration from taking effect. - Knowledge base query errors or inaccurate results: Peptide sequences or chemical structures were not correctly parsed and embedded, preventing the model from understanding their biological meaning, leading to poor recall quality.
- No response or timeout during Q&A: When processing large-scale peptide drug data,
PARSE_FILE_TIMEOUT_SECONDSormaxContextwere set too low, causing file parsing failures or model inference interruptions.
Verification Steps
- Upload a typical peptide drug clinical trial PDF file (e.g., containing peptide sequences, PK/PD curves, and adverse event lists). Check if the file successfully parses and segments into the knowledge base.
- Perform queries on the uploaded knowledge base, including peptide names, target sites, or specific biomarkers. Check if the recall results contain relevant document snippets and verify their accuracy.
- Simulate a complex question for a peptide drug pre-screening scenario. Observe if the model's response is logically clear, comprehensive, and references relevant information from the knowledge base. Also, check if the response time is within the expected range.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.